Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model

Overview

This protocol describes the induction of pulmonary hypertension (PH) in mice through hypoxia exposure and VEGF receptor antagonist injection. The model allows for functional and morphometrical characterization of PH and right ventricular hypertrophy within three weeks.

Key Study Components

Area of Science

• Neuroscience
• Cardiovascular Biology
• Pathophysiology

Background

• Pulmonary hypertension is a serious condition affecting the cardiovascular system.
• Understanding the mechanisms behind PH can lead to new therapeutic targets.
• The Sugen Hypoxia Model is a widely used method to study PH in mice.
• VEGF receptor antagonists play a role in the development of PH.

Purpose of Study

• To induce pulmonary hypertension in a controlled mouse model.
• To perform functional measurements of the right ventricle.
• To identify new pathways and therapeutic targets for PH.

Methods Used

• Induction of hypoxia by setting oxygen levels to 10%.
• Injection of SU5416 to block VEGF receptors.
• Monitoring of right ventricular function and morphology.
• Characterization of the model over a three-week period.

Main Results

• Development of pulmonary hypertension and right ventricular hypertrophy.
• Functional measurements indicate significant changes in right ventricular performance.
• Morphological changes consistent with pulmonary hypertension observed.
• Identification of potential new therapeutic targets for treatment.

Conclusions

• The Sugen Hypoxia Model effectively mimics pulmonary hypertension.
• This model can be used to explore new pathways involved in PH.
• Future studies can leverage this model for therapeutic testing.

Frequently Asked Questions